Wed, Sep 3, 2014, 12:07 AM EDT - U.S. Markets open in 9 hrs 23 mins

Recent

% | $
Quotes you view appear here for quick access.

NanoLogix Inc. Message Board

commishfree1 6 posts  |  Last Activity: 10 hours ago Member since: Mar 15, 2014
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Bashers Wanted

    by erickarther Aug 22, 2014 12:12 PM
    commishfree1 commishfree1 10 hours ago Flag

    And they had an Operations Manager on the job for about 2 years.....they posted $63,908 in 3rd qtr. 2012 sales with him aboard. Maybe Nanofanboy wants to see if Hank beat the number. Ya follow?

  • Reply to

    Bashers Wanted

    by erickarther Aug 22, 2014 12:12 PM
    commishfree1 commishfree1 Aug 31, 2014 11:31 AM Flag

    Erick--" if sales happen then PPS comes up."

    Great "pearl of wisdom" there chief..... when do you expect them to tell you about the sales happening...while you're young? Mixing dehydrated culture media with water, heating it, pouring it into empty petri plates and wrapping 'em up.....shouldn't take very long to "develop." Ya follow?

  • Reply to

    Bashers Wanted

    by erickarther Aug 22, 2014 12:12 PM
    commishfree1 commishfree1 Aug 31, 2014 10:37 AM Flag

    Erick 3 years ago --"I'm afraid we are heading back to the sub 40 cent area. I'm long and have patience but without sales, approvals, quarterlies and bigs that want to buy us ....... we have a yoo yoo..... up down"

    You must still be sitting on a bucket on a streetcorner...playing with your yo-yo. LOL

  • commishfree1 commishfree1 Aug 30, 2014 10:15 AM Flag

    All this "excitement" but no "deep pocket" interest. In contrast, look at T2Biosystems (TTOO) which debuted with an IPO @ $14/share earlier this month. Several investment groups were buying blocks of shares at $11/share pre-IPO. Stock closed Friday @$23. Now there is some "excitement". Same sector, rapid bacterial diagnostics, yet this one gets substantial interest and NNLX gets a late Friday "tape painter" putting up $80 to avoid a single digit close.

  • Reply to

    Bashers Wanted

    by erickarther Aug 22, 2014 12:12 PM
    commishfree1 commishfree1 Aug 26, 2014 12:14 PM Flag

    "NanoLogix (PINK SHEETS: NNLX), a biotechnology innovator in the rapid detection and identification of live-cell bacteria and microorganisms, announced today its BioNanoFilter (BNF) technology will undergo a clinical trial, led by Dr. Gian Carlo Di Renzo of the University of Perugia in Italy. The 300 patient trial will study the speed and accuracy of NanoLogix technology compared to current methods in the detection and identification of Group B Streptococcus (GBS) in pregnant women. Initial BNF results on GBS from the University of Texas Health Science Center-Houston show detection and identification within two to six hours. This is eight to twenty-four times faster than conventional methods. The trial will be the second clinical trial conducted on the NanoLogix BNF technology for Group B Strep. Results from this clinical trial will accelerate the approval of the BNF kits for use in Europe, North Africa and the Middle East. "

    The above from 3 years ago...nobody picked up the "slack" since this trial "did not happen"? How can you expect to "accelerate the approval of the BNF kits for use in Europe, North Africa and the Middle East" if there is no trial? Has the N-assay been used in a trial or is one planned? Pretty basic questions....but as you can see, I just deal with the fundamentals.

  • Reply to

    Future Timeline for NNLX

    by dlakersrok Aug 21, 2014 5:59 PM
    commishfree1 commishfree1 Aug 22, 2014 7:34 AM Flag

    Group B Streptococcus (GBS)
    "Developed and tested in the RVHB and utilising the LAMP platform, GBS has been licensed exclusively to HiberGene by the BHSCT. The GBS Test is targeted at pregnant women as up to 30% of them will be colonised with GBS in the #$%$ or rectum. If GBS is present during labour and birth it can be transmitted to the child with fatal consequences in up to 6% of cases. Intrapartum transmission of GBS can be prevented by administering antibiotics prior to delivery. Current culture methods of testing miss up to 50% of infections and take up to 48 hours.
    The HiberGene GBS has a sensitivity of 100% and a specificity of 95%, gives a positive result in under 10 minutes and requires up to 25 minutes for a negative result. The test is simple enough to perform in a labour ward and meets a clear and unmet clinical need as stipulated by the US Centre for Disease Control (CDC)"

    Irish company...HiberGene Diagnostics. RVHB is the Royal Victoria Hospital Belfast.

NNLX
0.100.00(0.00%)Aug 29 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.